Repligen (RGEN) News Today $145.74 +0.60 (+0.41%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Repligen Co. (NASDAQ:RGEN) Shares Sold by Zevenbergen Capital Investments LLCZevenbergen Capital Investments LLC lessened its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 12.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 112,747 shares of the biotechnology company's stock after selling 16March 25 at 7:32 AM | marketbeat.com4,635 Shares in Repligen Co. (NASDAQ:RGEN) Purchased by Fox Run Management L.L.C.Fox Run Management L.L.C. purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 4,635 shares of the biotechnology company's stock, valued at approximately $667,000.March 25 at 4:55 AM | marketbeat.comCritical Comparison: Repligen (NASDAQ:RGEN) and Cyclo Therapeutics (NASDAQ:CYTH)March 24 at 2:09 AM | americanbankingnews.comNatixis Advisors LLC Purchases 10,692 Shares of Repligen Co. (NASDAQ:RGEN)Natixis Advisors LLC boosted its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 31.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,317 shares of the biotechnology company's stock after buyMarch 23 at 3:54 AM | marketbeat.comInsider Buying: Margaret Pax Acquires Shares of Repligen Corp (RGEN)March 21, 2025 | gurufocus.comRepligen’s SWOT analysis: bioprocessing leader’s stock faces growth and valuation challengesMarch 21, 2025 | uk.investing.comRepligen Co. (NASDAQ:RGEN) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA cut its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 43.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 30,858 shares of the biotechnology company's stock after sellingMarch 21, 2025 | marketbeat.comRepligen: Ongoing Bioprocessing Market RecoveryMarch 20, 2025 | seekingalpha.comThrivent Financial for Lutherans Sells 33,482 Shares of Repligen Co. (NASDAQ:RGEN)Thrivent Financial for Lutherans lessened its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 5.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 605,120 shares of the biotechnology company's stock after selling 33,482 shares during thMarch 20, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Earns In-Line Rating from Analysts at Evercore ISIMarch 20, 2025 | americanbankingnews.comRepligen Director Makes a Multi-Million Dollar Stock Move!March 19, 2025 | tipranks.comRepligen Co. (NASDAQ:RGEN) Director Margaret Pax Purchases 250 SharesRepligen Co. (NASDAQ:RGEN - Get Free Report) Director Margaret Pax bought 250 shares of the stock in a transaction on Monday, March 17th. The shares were acquired at an average cost of $150.69 per share, for a total transaction of $37,672.50. Following the completion of the transaction, the director now directly owns 1,043 shares of the company's stock, valued at approximately $157,169.67. The trade was a 31.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.March 19, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Shares Gap Down - Here's What HappenedRepligen (NASDAQ:RGEN) Shares Gap Down - Here's What HappenedMarch 19, 2025 | marketbeat.comEvercore ISI Begins Coverage on Repligen (NASDAQ:RGEN)Evercore ISI assumed coverage on shares of Repligen in a report on Tuesday. They set an "in-line" rating and a $155.00 price target on the stock.March 19, 2025 | marketbeat.comMargaret Pax Buys 250 Shares of Repligen Co. (NASDAQ:RGEN) StockMarch 19, 2025 | insidertrades.comProficio Capital Partners LLC Makes New Investment in Repligen Co. (NASDAQ:RGEN)Proficio Capital Partners LLC acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 21,303 shares of the biotechnology company's stockMarch 19, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. lessened its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 27.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,908 shares of the biotechnology company's stocMarch 19, 2025 | marketbeat.com5RGEN : Demystifying Repligen: Insights From 6 Analyst ReviewsMarch 18, 2025 | benzinga.comEvercore ISI Group Initiates Coverage of Repligen (RGEN) with In-Line RecommendationMarch 18, 2025 | msn.comRepligen down 7% as Evercore initiates in-lineMarch 18, 2025 | seekingalpha.comRepligen initiated with an In Line at Evercore ISIMarch 18, 2025 | markets.businessinsider.comQ4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services StocksMarch 17, 2025 | msn.comPolen Capital Management LLC Buys 5,173 Shares of Repligen Co. (NASDAQ:RGEN)Polen Capital Management LLC lifted its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 14.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 40,556 shares of the biotechnology company's stock after purchasing an additionMarch 17, 2025 | marketbeat.comRepligen Corp (RGEN) Shares Up 5.72% on Mar 17March 16, 2025 | gurufocus.comRepligen Corp (RGEN) Shares Up 5.72% on Mar 15March 15, 2025 | gurufocus.comParnassus Investments LLC Sells 15,239 Shares of Repligen Co. (NASDAQ:RGEN)Parnassus Investments LLC reduced its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 4.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 366,232 shares of the biotechnology company's stock after selMarch 15, 2025 | marketbeat.comAmundi Raises Holdings in Repligen Co. (NASDAQ:RGEN)Amundi grew its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 85,863 shares of the biotechnology company's stock after purchasing an additional 8,790 shares during tMarch 15, 2025 | marketbeat.comDaiwa Securities Group Inc. Has $3.46 Million Holdings in Repligen Co. (NASDAQ:RGEN)Daiwa Securities Group Inc. raised its position in Repligen Co. (NASDAQ:RGEN - Free Report) by 29.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,046 shares of the biotechnology company's stock after purchasing an aMarch 14, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Grows Position in Repligen Co. (NASDAQ:RGEN)Charles Schwab Investment Management Inc. lifted its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 4.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 377,900 shares of the biotechnology compMarch 14, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Shares Up 5.4% - Here's What HappenedRepligen (NASDAQ:RGEN) Shares Up 5.4% - What's Next?March 12, 2025 | marketbeat.comWilliam Blair Issues Negative Forecast for Repligen EarningsRepligen Co. (NASDAQ:RGEN - Free Report) - Stock analysts at William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of Repligen in a note issued to investors on Monday, March 10th. William Blair analyst M. Larew now forecasts that the biotechnology company will post eMarch 12, 2025 | marketbeat.comRaymond James Financial Inc. Makes New Investment in Repligen Co. (NASDAQ:RGEN)Raymond James Financial Inc. bought a new position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 364,681 shares of the biotechnMarch 12, 2025 | marketbeat.comEdgestream Partners L.P. Acquires New Position in Repligen Co. (NASDAQ:RGEN)Edgestream Partners L.P. acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,411 shares of the biotechnology company's stock, valued at apMarch 11, 2025 | marketbeat.comCallan Family Office LLC Invests $434,000 in Repligen Co. (NASDAQ:RGEN)Callan Family Office LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,016 shares of the biotechnology company's stock, valued at approximatMarch 10, 2025 | marketbeat.comGeneva Capital Management LLC Cuts Stock Position in Repligen Co. (NASDAQ:RGEN)Geneva Capital Management LLC cut its holdings in Repligen Co. (NASDAQ:RGEN - Free Report) by 2.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 135,585 shares of the biotechnology company's stock after selling 3,092 shMarch 7, 2025 | marketbeat.com21,303 Shares in Repligen Co. (NASDAQ:RGEN) Acquired by Proficio Capital Partners LLCProficio Capital Partners LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 21,303 shares of the biotechnology company's stock, valued at approximately $3,066,000. OtheMarch 6, 2025 | marketbeat.comTD Cowen Keeps Their Buy Rating on Repligen (RGEN)March 6, 2025 | markets.businessinsider.comRepligen’s Strategic Acquisition: Hold Rating Amid Short-term Financial Dilution and Long-term Growth PotentialMarch 5, 2025 | tipranks.comCraig-Hallum Remains a Buy on Repligen (RGEN)March 4, 2025 | markets.businessinsider.com908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future GrowthMarch 4, 2025 | benzinga.comRepligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy RatingMarch 4, 2025 | tipranks.comRepligen acquires bioprocessing analytic portfolio from 908 Devices for $70MMarch 4, 2025 | markets.businessinsider.comRepligen Purchases Bioprocessing Analytics Portfolio from 908 DevicesMarch 4, 2025 | globenewswire.comNBW Capital LLC Buys 4,152 Shares of Repligen Co. (NASDAQ:RGEN)NBW Capital LLC grew its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 19.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,194 shares of the biotechnology company's stock after purchasing an additionaMarch 4, 2025 | marketbeat.comRepligen Delays 2024 Yearly Report FilingMarch 3, 2025 | tipranks.comAnalysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB) and Repligen (RGEN)March 3, 2025 | markets.businessinsider.comRepligen Co. (NASDAQ:RGEN) Stake Lessened by Oppenheimer Asset Management Inc.Oppenheimer Asset Management Inc. cut its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 16.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,567 shares of the biotechnology company's stoMarch 3, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Repligen Co. (NASDAQ:RGEN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the thirteen ratings firms that are covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating on theMarch 3, 2025 | marketbeat.comVersor Investments LP Lowers Stock Position in Repligen Co. (NASDAQ:RGEN)Versor Investments LP cut its stake in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 43.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,367 shares of the biotechnology company's stock after selling 2,March 2, 2025 | marketbeat.comGuru Fundamental Report for RGEN - Benjamin GrahamMarch 1, 2025 | nasdaq.com Remove Ads Get Repligen News Delivered to You Automatically Sign up to receive the latest news and ratings for RGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address RGEN Media Mentions By Week RGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGEN News Sentiment▼0.910.63▲Average Medical News Sentiment RGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGEN Articles This Week▼217▲RGEN Articles Average Week Remove Ads Get Repligen News Delivered to You Automatically Sign up to receive the latest news and ratings for RGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News United Therapeutics News BioMarin Pharmaceutical News Incyte News Neurocrine Biosciences News Exelixis News Exact Sciences News Halozyme Therapeutics News Madrigal Pharmaceuticals News Alkermes News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGEN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RGEN Stock Free RGEN Stock Alerts